Company
Cullgen
Powering protein degradation for tomorrow’s medicines.
Also known as Cullgen Inc.
- Status
- Acquiredas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- San Diego, California, United States
- Legal name
- Cullgen Inc.
- cullgen.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Cullgen is a privately held biopharmaceutical company dedicated to the development of first-in-class medicines for the treatment of diseases lacking effective therapeutic approaches. We utilize our proprietary technology platform to build the next generation of targeted protein degraders and degrader antibody conjugates (DACs).
About the company
- Status notes
- GYRE THERAPEUTICS COMPLETES ACQUISITION OF CULLGEN TO CREATE U.S.- AND CHINA-BASED FULLY INTEGRATED BIOPHARMACEUTICAL COMPANY.
Products
- Other
- CG001419
Exit
- Acquisition
- $300M, 2026-05-04approximately $300 million
Loading relationship preview